InvestorsHub Logo

GS1

06/22/20 6:28 AM

#5568 RE: Rogerthat1 #5567

I think they are treating patients under expanded access protocol per clinical trials website. FDA has approved to treat upto 20 patients. Once that is done + 30 day followup will be used to measure survival and if all goes well then FDA may grant them EUA approval.

I think they can treat upto 100 patients under intermediate use protocol but Im not sure if they are doing it.

mick

06/22/20 1:30 PM

#5574 RE: Rogerthat1 #5567

$CAPR reading 20ma 50ma are kissing !!!!!



[-chart]finviz.com/chart.ashx?t=CAPR&ty=c&ta=1&p=d&s=l[/chart]